VSY Biotechnology Presents Acriva Trinova Pro C at the APACRS Congress
VSY Biotechnology participated in the 35th APACRS Congress held at the Suntec Singapore Convention & Exhibition Centre in Singapore from June 8-10, 2023.
The company showcased its latest product, the AcrivaUD Trinova Pro C Pupil Adaptive® with Sinusoidal Vision Technology (SVT®), which garnered attention from attendees. This innovative intraocular lens aims to enhance visual outcomes for cataract patients and revolutionize the field of ophthalmology.
The AcrivaUD Trinova Pro C Pupil Adaptive® IOL integrates Sinusoidal Vision Technology (SVT®), a revolutionary advancement that enhances visual quality and expands the range of focus for patients. The adaptable nature of the lens ensures optimal vision in various lighting conditions and pupil sizes, setting a new standard for optics technology.
The state-of-the-art IOL redefines cataract surgery by significantly reducing glare, halos, and other visual disturbances, and offers a “Golden Ratio” vision experience without the need for spectacles.
The 35th APACRS Congress provided an ideal platform for VSY Biotechnology to engage with leading ophthalmic professionals, researchers, and surgeons from around the world. The event offered a valuable opportunity for knowledge exchange, networking, and collaborative discussions on the latest advancements in cataract surgery and intraocular lens technology. VSY Biotechnology's participation in the congress further strengthens its commitment to innovation and its role as a key player in the ophthalmic industry.
In addition to its successful participation at the APACRS Congress, VSY Biotechnology is gearing up for another major event this year. The company has exciting plans to launch new products at the 41st Congress of the ESCRS, which will be held at the Messe Wien Exhibition & Congress Centre from 8-12 12, 2023.
The ESCRS Congress is a renowned gathering of ophthalmic professionals and industry experts from around the world. VSY Biotechnology aims to showcase its latest innovations and contribute to the advancements in ophthalmic technology at this prestigious event.
